Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), TGF-β inhibitors(Transforming growth factor beta inhibitors), Immunologic cytotoxicity + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Phase 1 | US | 08 Mar 2017 |